Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Method and apparatus for managing communication services for user endpoint devices
Recombinant negative strand virus RNA expression systems and vaccines
System and method for access of user accounts on remote servers
System and method for monitoring network activity
Potato cultivar F10
Difference detecting apparatus, difference output apparatus, and medium
Organic electroluminescence device
  Randomly Featured Patents
All optical chromatic and polarization mode dispersion correctors
Semiconductor device with reduced capacitance
Apparatus for aligning multiple projected images in cockpit displays
Mordanting substrates and agents
Inactivated vaccines for aids and other infectious diseases
Subscriber interface for a fiber optic communications terminal
Stepping motor
Identification bracelet
Power train for hybrid vehicle